Paradeep Phosphates Q2 FY27 slides: revenue rises 7% as margins compress

Paradeep Phosphates’ Q2 FY27 revenue rose 7.2% year over year to INR 73,641 million, but EBITDA fell 38.3% to INR 4,312 million and net profit declined 64.1% to INR 1,224 million; shares fell 6.58% following the results. Margin pressure, an INR 60 crore inventory write-down, and working-capital strain accompanied net working capital of 116 days and total debt of INR 98,472 million in H1 FY27. Management expects H2 EBITDA per ton of INR 4,500–5,000 versus INR 4,250 in Q2 and expects debt to decline as inventory is liquidated and subsidy collections improve.

Analysis

The equity risk is shifting from an input-cost story to a cash-conversion test: subsidy receivables and inventory tie up capital just as margins weaken, making delayed collections more consequential than another quarter of modest volume growth. Lower sulphur prices would help only with a lag if high-cost stock remains on hand; meanwhile a greater reliance on traded product can preserve distribution but may dilute manufacturing leverage and keep working capital elevated. Track margin per ton alongside receivable aging, inventory liquidation and net debt—not headline revenue.

Near term, the selloff may have captured much of the earnings disappointment, and management’s H2 margin-per-ton range offers a possible recovery path. But it is guidance, not evidence of recovery; policy notifications, farmer purchasing behavior and import logistics can still disrupt both pricing and cash collection. Over 1–3 months, the key catalyst is whether subsidy receipts and Rabi inventory liquidation translate into lower debt by year-end. Failure would make leverage and liquidity the dominant debate. Over 6–18 months, backward integration could reduce exposure to imported phosphoric acid, but the claimed savings and EBITDA contribution need validation against commissioning, utilization and funding needs; planned capex competes with balance-sheet repair.

Contrarian: the market may be treating the quarter’s margin trough as persistent, while softer inputs and working-capital normalization could produce a sharp earnings/cash-flow rebound. Conversely, the more important downside may be underestimated: even improving EBITDA does not repair equity value if receivables stay trapped and debt remains high. The article’s volume descriptions use differing scopes; verify comparable product/period data before treating volume resilience as a thesis.

Key Decisions for Investors

• Stay underweight Paradeep Phosphates / avoid adding on the earnings dip until the next disclosure confirms subsidy collections, inventory reduction and net-debt direction. Reassess if these improve together; a margin rebound without cash conversion is not sufficient.
• Use a conditional short or hedge in Paradeep Phosphates over the next 1–3 months only if year-end debt fails to decline materially, receivables remain elevated, or realized EBITDA per ton falls below management’s H2 range. Cover on verified collection-led deleveraging; avoid an unconditional short given potential input-cost relief and rebound risk.
• For relative value, consider pairing a smaller Paradeep Phosphates exposure against a fertilizer peer only after comparing subsidy-receivable days, net leverage, import/raw-material mix and valuation. Those peer data are missing here; do not assume peers are insulated from the same policy or logistics shocks.
• Monitor sulphur prices and procurement lead times, subsidy notification/payment timing, inventory aging, traded-product share and project funding. Falsification of the recovery thesis: continued debt accumulation despite improved inputs, further inventory write-downs, or guidance cuts; confirmation: cash-led debt reduction alongside sustained per-ton margins.